Rubius Therapeutics, Inc.

UBS Group AG

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/8/2023

Shares

72,662

Value ($000)

13

Weight

0.0%

2019 Q4 - 2022 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/8/2023	13	0.0%	72,662	12/31/2022
2022 Q3	11/10/2022	5	0.0%	11,986	9/30/2022
2022 Q1	5/16/2022	3	0.0%	522	3/31/2022
2021 Q4	2/14/2022	1,028	0.0%	106,204	12/31/2021
2021 Q3	11/15/2021	1,457	0.0%	81,470	9/30/2021
2021 Q2	8/13/2021	235	0.0%	9,633	6/30/2021
2021 Q1	5/12/2021	294	0.0%	11,111	3/31/2021
2020 Q4	2/11/2021	22	0.0%	2,880	12/31/2020
2020 Q3	11/12/2020	5	0.0%	1,000	9/30/2020
2020 Q2	7/31/2020	14	0.0%	2,288	6/30/2020
2020 Q1	5/1/2020	56	0.0%	12,714	3/31/2020
2019 Q4	2/14/2020	354	0.0%	37,222	12/31/2019